The Pharma Data

DECEMBER 11, 2020

The collaborating entities have claimed that having quantitative data on neutralizing antibodies would enable a better understanding of a person’s immune response following exposure to the Covid-19 virus and would support monitoring the effectiveness of vaccines available to the UK population.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

The Pharma Data

NOVEMBER 1, 2020

The BD Veritor Plus System is already in use across Europe to detect Influenza A+B, Respiratory Syncytial Virus (RSV), and Group A Strep. View original content to download multimedia: [link]. .” The BD Veritor Plus System is a portable, easy-to-use device that makes it an ideal solution for point-of-care settings. Source link.

Laboratories 52

Laboratories Virus FDA Government 52

The Pharma Data

SEPTEMBER 24, 2020

” Meanwhile, people living in England and Wales are being urged to download the government’s contact-tracing app following its official release. NHS Covid-19 instructs users to self-isolate for 14 days if it detects they were nearby someone who has the virus.

Government 52

Government Virus Hospitals 52

The Pharma Data

OCTOBER 26, 2020

Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” ” Panel: Direct Antivirals and Other Agents Against SARS-CoV2 Virus Date: Wednesday, October 28, 2020 Time: 10:30AM- 11:50AM ET. Source link.

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

DECEMBER 21, 2020

The path forward through this pandemic must include identifying, treating and tracing as many cases of COVID-19 as possible as we work to suppress this virus.” View original content to download multimedia: [link]. Media Contact: Marc Brown marc.t.brown@kp.org 510-407-2592. SOURCE Kaiser Permanente. Source link.

Virus 52

Virus Clinical Research Treatment Disease 52

The Pharma Data

SEPTEMBER 25, 2020

The rate at which the Covid-19 virus is spreading appears to be speeding up. In contrast, the ONS survey suggest there were actually 103,600 people in England with the virus, equating to an estimated one in 500 people in private homes. Image copyright. Getty Images. The number does not include cases in hospitals and care homes.

Virus 40

Virus Hospitals 40

The Pharma Data

DECEMBER 30, 2020

31, 2020 /PRNewswire/ — ImmVira Group Company (“the Company”), a biotechnology platform dedicated to the development of oncolytic virus(“OV”) and vector type approaches to create more effective and safer therapies against cancer, announced today the signing of Series C financing. .

Virus 40

Virus International Trials Clinical Trials 40

The Pharma Data

DECEMBER 20, 2020

20 , 2020 /PRNewswire/ — The broad spectrum antiviral therapeutic, ‘hzVSF-v13(humanized Virus Suppressing Factor)’ being developed by ImmuneMed , is on track to progress as a treatment for the COVID-19 pneumonia patients. View original content to download multimedia: [link]. CHUNCHEON, South Korea , Dec.

Clinical Trials 40

Clinical Trials Treatment Trials Hospitals 40

The Pharma Data

JANUARY 12, 2021

View original content to download multimedia: [link]. The LumiraDx SARS-CoV-2 Antigen test is authorized for use by FDA under an Emergency Use Authorization (EUA) only for the detection of SARS-CoV-2 nucleocapsid protein. It has not been authorized for use to detect any other viruses or pathogens. SOURCE LumiraDx. Source link.

Laboratories 52

Laboratories Virus FDA Marketing 52

The Pharma Data

OCTOBER 15, 2020

JUD care’s portable ward sROOM, which well represents our mission, Empower Healthcare with Technology and Commence, is a revolutionary solution for instant isolation, helping medical staff to implement fast and reliable interventions to contain the spread of virus, as well as safeguard human health.” SOURCE JUD care.

International 52

International Hospitals Virus Disease 52

The Pharma Data

DECEMBER 28, 2020

View original content to download multimedia: [link]. . HOUSTON , Dec. 29, 2020 /PRNewswire/ — Moleculin Biotech , Inc., Moleculin Biotech, Inc. . SOURCE Moleculin Biotech, Inc. . Source link.

FDA 52

FDA Clinical Trials Drugs Pharmaceutical Companies 52

The Pharma Data

JANUARY 20, 2021

View original content to download multimedia: [link]. The LumiraDx SARS-CoV-2 Antigen Test is authorized for use by FDA under an Emergency Use Authorization (EUA) only for the detection of SARS-CoV-2 nucleocapsid protein. It has not been authorized for use to detect any other viruses or pathogens. SOURCE LumiraDx. Source link.

Virus 52

Virus Hospitals FDA Pharmaceuticals 52

The Pharma Data

NOVEMBER 1, 2020

REGENXBIO’s NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. View original content to download multimedia: [link]. Contact: Amy Conrad , 858-366-3243, amy@juniper-point.com.

Therapies 52

Therapies Science Treatment Disease 52

The Pharma Data

OCTOBER 16, 2020

Novan has been evaluating the ability of its NITRICIL platform technology as a potential nasal treatment option for Covid-19, announcing its potential efficacy as an antiviral against SARS-CoV-2, the virus that causes Covid-19. Source link.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

The Pharma Data

OCTOBER 28, 2020

“We have gained momentum in testing for the COVID-19 virus, with approximately 30,000 sample received during the past three weeks alone, and are continually adding more equipment and human resources to accommodate additional growth and peak daily sample volume,” said Michael Nall , President and CEO of Biocept.

Virus 40

Virus DNA Laboratories Disease 40

The Pharma Data

JANUARY 22, 2021

Patrick Soon-Shiong MD, chairman and CEO of ImmunityBio, said: “There is an urgent need for a vaccine that not only offers immediate protection but also activates T cells to clear the virus. Download this exclusive report here.

Vaccine 52

Vaccine Immune Response Government RNA 52

The Pharma Data

DECEMBER 30, 2020

. About Test & Trace Corps The Test & Trace Corps is the City’s comprehensive effort to test, trace, and provide support for every case of COVID-19 and every person exposed to the virus that causes COVID-19. View original content to download multimedia: [link]. .

Nurses 52

Nurses Hospitals Virus Licensing 52

The Pharma Data

JANUARY 31, 2021

The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus. View original content to download multimedia: [link]. . .

Small Molecule 40

Small Molecule FDA Approval Therapies Trials 40

The Pharma Data

OCTOBER 20, 2020

View original content to download multimedia: [link]. . HOUSTON , Oct. 21, 2020 /PRNewswire/ — Moleculin Biotech , Inc., Moleculin Biotech, Inc. . . . SOURCE Moleculin Biotech, Inc. .

Clinical Trials 40

Clinical Trials Pharmaceutical Companies Treatment Immune Response 40

The Pharma Data

OCTOBER 19, 2020

View original content to download multimedia: [link]. Winship Cancer Institute Media Contact: Catherine Williams Associate Director, Communications and Media Relations catherine.s.williams@emory.edu 404-778-5848. SOURCE Caris Life Sciences. Source link.

Clinical Trials 52

Clinical Trials RNA DNA Science 52

The Pharma Data

SEPTEMBER 17, 2020

“Based on our initial clinical studies, we believe that virus neutralizing antibodies, including LY-CoV-555, could play an important role in the fight against COVID-19,” said Daniel Skovronsky , M.D., View original content to download multimedia: [link]. Securities and Exchange Commission. SOURCE Eli Lilly and Company.

Therapies 52

Therapies Production Government Disease 52

The Pharma Data

NOVEMBER 9, 2020

View original content to download multimedia: [link]. About Tezepelumab Tezepelumab is an investigational, potential first-in-class human monoclonal antibody that works on the primary source of inflammation: the airway epithelium, which is the first point of contact for viruses, allergens, pollutants, and other environmental insults.

Trials 52

Trials Production Clinical Trials Government 52

The Pharma Data

NOVEMBER 4, 2020

View original content to download multimedia: [link]. Except as expressly required by applicable Canadian securities law, the Company assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. . .

Licensing 40

Licensing Licensing Production Engineering 40

The Pharma Data

DECEMBER 21, 2020

View original content to download multimedia: [link]. Specifically, tezepelumab targets and blocks TSLP, a key epithelial cytokine that sits at the top of multiple inflammatory cascades and initiates an overreactive immune response to allergic, eosinophilic and other types of airway inflammation associated with severe asthma.

Trials 40

Trials Production Clinical Trials Therapies 40

The Pharma Data

SEPTEMBER 24, 2020

People living in England and Wales are being urged to download the government’s official contact-tracing app following its official release. NHS Covid-19 instructs users to self-isolate for 14 days if it detects they were nearby someone who has the virus. Coronavirus pandemic. Barcode check-ins.

Government 52

Government Virus Trials Hospitals 52

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 134

Therapies Virus DNA Clinical Trials 134

The Pharma Data

AUGUST 28, 2020

Following a low point in June in the percentage of people testing positive for the virus, there was a small increase in July. The Covid Symptom study app , which has been downloaded by nearly four million people in the UK, suggests a low level of the virus within most of the population. Source link.

Virus 52

Virus Government Hospitals Research 52

The Pharma Data

JANUARY 21, 2021

Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. View original content to download multimedia: [link].

FDA Approval 52

FDA Approval Treatment RNA FDA 52

The Pharma Data

SEPTEMBER 10, 2020

Dr Nagpaul added the idea of opening up society based on people testing negative for the virus should be “approached with caution” because of the high rate of “false negatives” and the potential to miss those who are incubating the virus. Distraction from difficult decisions ahead.

Virus 52

Virus Government Laboratories Treatment 52

The Pharma Data

DECEMBER 20, 2020

BT-001 is a best-in-class oncolytic Vaccinia virus. platform and its patented large-capacity VV cop TK-RR- oncolytic virus, which has been engineered to encode both a Treg-depleting human recombinant anti-CTLA4 antibody generated by BioInvent’s proprietary n-CoDeR ® /F.I.R.S.T LUND, Sweden and STRASBOURG, France , Dec.

Virus 40

Virus Trials Clinical Trials Clinical Development 40

The Pharma Data

DECEMBER 18, 2020

The vaccine contains a small piece of the SARS-CoV-2 virus’s mRNA that instructs cells in the body to make the virus’s distinctive “spike” protein. View original content to download multimedia: [link]. The Moderna COVID-19 Vaccine contains messenger RNA (mRNA), which is genetic material. SOURCE U.S.

Vaccine 52

Vaccine FDA Clinical Trials FDA Approval 52

The Pharma Data

NOVEMBER 18, 2020

It works to block the “spike protein” in the virus before it can enter human cells and cause illness. Introduction of a monoclonal antibody in a sick person essentially neutralizes the virus and stops it from worsening and spreading. View original content to download multimedia: [link].

Hospitals 40

Hospitals Treatment Virus Nurses 40

The Pharma Data

NOVEMBER 21, 2020

Casirivimab and imdevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells. View original content to download multimedia: [link]. acting director of the FDA’s Center for Drug Evaluation and Research.

FDA 40

FDA Treatment Hospitals Clinical Trials 40

The Pharma Data

DECEMBER 1, 2020

The WHO COVID-19 app works with devices running iOS [version X and up] and with devices running Android [version X and up], and can be downloaded here. The app gives users information about COVID-19 symptoms and how to protect themselves and their community from the virus. What is launching? What does the app do?

Virus 52

Virus Vaccine Research 52

The Pharma Data

NOVEMBER 28, 2020

Two things are being asked of us: to follow local public health advice as measures are introduced for controlling spread across the population and to strictly and consistently maintain our individual protective practices to help prevent infection and spreading the virus. Every effort you can make matters.

Hospitals 40

Hospitals Laboratories Virus Disease 40

The Pharma Data

NOVEMBER 14, 2020

Larger clusters tell us that closed spaces with poor ventilation, crowded places where many people gather and close contact situations can amplify spread of the virus. With colder weather, we are moving indoors. Jurisdictions continue to highlight informal social gatherings and activities as an important driver for spread.

Assisted Living 40

Assisted Living Hospitals Laboratories Virus 40

The Pharma Data

NOVEMBER 7, 2020

As our activities move indoors during the colder weather, I am advising Canadians to avoid the 3Cs settings wherever possible; larger clusters tell us that closed spaces with poor ventilation, crowded places where many people gather and close contact situations can amplify spread of the virus.

Assisted Living 40

Assisted Living Hospitals Laboratories Disease 40